Month: March 2023

News New Drugs FDA Approves Expanded Indication for Telix’s Illuccix to Include Patient Selection for PSMA-Directed Radioligand Therapy Indianapolis, IN (United States) | 16 March 2023 — Telix Pharmaceuticals today announces that the United States Food and Drug Administration (FDA) has approved a supplementary New Drug Application (sNDA) for Illuccix® (kit for the preparation of
0 Comments
A potential harmful algae could impact beachgoers during spring break. ____________________________________________ For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where other safety protocols were followed. FOR
0 Comments
You may have heard about a new study into contraception and cancer recently. New information about cancer risks can be hard to apply to everyday life, and headlines about this paper are highlighting some alarming-looking numbers. If you or someone you’re close to uses hormonal contraception, there’s a chance you’re asking what the latest findings
0 Comments
The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Why This Matters Liver metastases are common among patients with NETs. Surgical debulking relieves symptoms and improves long-term survival. Parenchymal-sparing liver resection with microwave ablation is one surgical option, but reports on patient
0 Comments
Time to Eat? Why Timing Matters for People With Diabetes – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be
0 Comments
CAPE CANAVERAL, Fla., March 20, 2023. Vaxxinity, Inc., a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that the first subjects have been dosed in a randomized, double-blind, placebo-controlled Phase 1 clinical trial of VXX-401, an investigational vaccine designed to lower low-density lipoprotein (LDL) cholesterol, a known factor contributing
0 Comments
In a recent study published in the Proceedings of the National Academy of Sciences, researchers assessed the association between cross-reactive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) CD4+ T cells generation and age. Since immunological reactions against SARS-CoV-2 have been found in samples collected prior to the coronavirus disease 2019 (COVID-19) pandemic, the clinical significance
0 Comments
U.S. President Joe Biden delivers remarks during a reception celebrating Nowruz in the East Room at the White House in Washington, March 20, 2023. Kevin Lamarque | Reuters President Joe Biden on Monday signed legislation requiring the Office of the Director of National Intelligence to declassify information on any possible links between a lab in
0 Comments
Tofersen, an investigational antisense drug developed to treat amyotrophic lateral sclerosis (ALS) associated with a mutation in the SOD1 gene (SOD1-ALS), may have clinical benefit, FDA reviewers indicated in briefing documents ahead of an advisory committee meeting. On Wednesday, the Peripheral and Central Nervous System Drugs Advisory Committee will vote on whether evidence supporting a
0 Comments
INDIANAPOLIS, March 3, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for Verzenio (abemaciclib), in combination with endocrine therapy (ET), for the adjuvant treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), node-positive, early
0 Comments
Even relatively small changes in cardiorespiratory fitness (CRF) are associated with “considerable” impact on clinical symptoms and mortality risk among individuals with and without cardiovascular disease, new observational data in United States veterans suggest. “We had a few surprises,” Peter Kokkinos, PhD, Rutgers University, New Brunswick, New Jersey, and the VA Medical Center, Washington, DC,
0 Comments
Type 1 diabetes is complicated. It’s okay to have questions. Get informed: https://mayocl.in/3MUSKkr. If you or someone you know has been diagnosed with diabetes, you may be asking yourself a lot of questions. Our experts are here to help you answer them. 0:00 Introduction 0:18 What is the best treatment for type 1 diabetes? 0:55
0 Comments
Editor’s Note: Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information and tools designed to improve your well-being. CNN  —  Potentially toxic chemicals found in everyday products, including fast-food wrappers, makeup and carpeting, are altering hormonal and metabolic pathways needed for human growth
0 Comments
JOHANNESBURG/LONDON, March 17 (Reuters) – Health officials in Burundi and the Democratic Republic of Congo (DRC) have detected cases of vaccine-derived poliovirus, the World Health Organization and Global Polio Eradication Initiative said. The WHO said the Burundian government had declared the detection of the virus a national public health emergency, after cases were confirmed in
0 Comments
5 Things That Can Happen After You Stop Taking Ozempic – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be
0 Comments
Chances of disability among survivors of hemorrhage are high, especially when it comes to long-term neurological deficits. Now, doctors have weighed the potential of a protein to treat this condition. The protein in focus is called cerebral dopamine neurotrophic factor (CDNF), which has a demonstrated history of reducing Endoplasmic Reticulum stress, and is being tested for
0 Comments
On National Close the Gap Day (Thursday 16 March), Diabetes WA is calling for greater recognition of the disproportionate impact of diabetes on Aboriginal Communities in Western Australia. Aboriginal West Australians are at far greater risk of diabetes and diabetes-related complications than any other community in the State.  Image Credit: Diabetes WA Aboriginal West Australians
0 Comments
The understanding of the impact of disturbed sleep on health-related quality of life (HRQOL) among healthy children is quite limited. To address this gap, a new JAMA Network Open study aimed to research the effect of sleep deprivation on HRQOL in healthy children without major sleep issues. Study: Effect of Sleep Changes on Health-Related Quality
0 Comments
NEW ORLEANS — Patients with severe alopecia areata had dramatic hair regrowth at 6 months with an investigational Janus kinase (JAK) inhibitor, according to a study reported here. Almost 40% of patients had at least 80% scalp coverage with the higher of two doses of the JAK 1/2 inhibitor deuruxolitinib (CTP-543), including 35% who had
0 Comments